The United States leads as the top importer of sulphonamides with a significant market value, followed by Belgium and France. Year-on-year data indicates a strong demand in these countries, with Europe showing a consistent presence in the market. Japan and Germany also play substantial roles, albeit with smaller values. Emerging markets such as China and Brazil show growth potential but remain behind their Western counterparts in terms of import value. The overall compound annual growth rate (CAGR) highlights stable increases across several countries over the last five years.
Future trends to watch for include:
- Increased demand from emerging markets like China and Brazil as their pharmaceutical industries expand.
- Potential shifts in import patterns due to changes in global trade policies and pharmaceutical innovations.
- Monitoring of regulatory changes affecting import tariffs and supply chain efficiencies on a global scale.
Top countries in Top Importers of Sulphonamides
| # | 10 Countries | Million US Dollars | Last Year | |
|---|---|---|---|---|
| 1 | 1 United States | 4,190 | 2016 | |
| 2 | 2 Belgium | 2,560 | 2016 | |
| 3 | 3 France | 1,700 | 2016 | |
| 4 | 4 Panama | 870.92 | 2016 | |
| 5 | 5 Japan | 455.99 | 2016 | |
| 6 | 6 Germany | 293.45 | 2016 | |
| 7 | 7 Ireland | 276.07 | 2016 | |
| 8 | 8 China | 172.2 | 2016 | |
| 9 | 9 Italy | 152.58 | 2016 | |
| 10 | 10 Brazil | 146.69 | 2016 |
